Jul 23, 2025, 09:47 by

Jul 22, 2025, 01:00 by User Not Found

Clinical Research News | Scientists at Virginia Commonwealth University (VCU) are tackling the massive computational problem of determining the distinct types of cells inhabiting biopsied tissue. Their endgame is to deploy a suite of interoperable artificial intelligence (AI) tools that can accurately and reliably guide prescribing decisions for patients with cancer as well as predict their response to investigational treatments prior to enrollment.

Jul 18, 2025, 01:00 by User Not Found

Clinical Research News | Imagine trying to piece together a puzzle with half the pieces missing—that’s what happens when data is siloed. Without integrated, centralized data across sources, data decisions are made using incomplete, fragmented datasets.

Jul 17, 2025, 08:13 by

Jul 17, 2025, 08:13 by

Jul 17, 2025, 01:00 by User Not Found

Clinical Research News | As gastrointestinal (GI) trials grow more sophisticated, the volume, velocity, and variety of study data have all expanded. One of the fastest-growing streams is electronic patient-reported outcomes (ePROs): diaries, symptom scores, quality-of-life surveys, and other instruments that come straight from the participant. Collecting this data quickly and conveniently is now mission critical.

Jul 16, 2025, 09:25 by

Three-in-one system integrates large fragment analytics, DNA size selection and fluorometric quantification for long-read sequencing

Jul 16, 2025, 09:25 by

Jul 15, 2025, 09:16 by

Jul 15, 2025, 01:00 by User Not Found

Clinical Research News | A fragmentation-based blood test is providing pharmaceutical companies with a new way to monitor cancer treatment response in clinical trials, informing how drug efficacy is evaluated in early-stage development. Delfi Diagnostics has developed DELFI-TF (DELFI-tumor fraction), a research-grade assay that uses a unique fragmentation approach to detect circulating tumor DNA in blood samples.

Jul 11, 2025, 01:00 by User Not Found

Clinical Research News | Feasibility, site selection, and study startup remain some of the most time-consuming and unpredictable phases of drug development. They are also tightly interconnected, making even small delays or inefficiencies during this period especially impactful, rippling across a study’s timeline and budget and affecting site relationships and patient access.

Jul 10, 2025, 10:12 by

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received UK Conformity Assessed (UKCA) marking for its Avantect® Pancreatic Cancer Test. The UKCA mark, established as part of the United Kingdom’s independent product safety regulatory framework following its departure from the European Union, signifies compliance with UK medical device regulations and paves the way for commercial availability in the UK market.

Jul 9, 2025, 09:34 by

New hire elevates strategic labeling solutions to support faster approval and smarter commercialization

Jul 9, 2025, 09:34 by

Nottingham, UK – [07.07.2025] – Upperton Pharma Solutions, a leading Nottingham-based pharmaceutical contract development and manufacturing organisation (CDMO), is delighted to announce its recognition as the winner of the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.

Jul 9, 2025, 01:00 by User Not Found

Clinical Research News | The growing importance of pragmatic clinical trials in healthcare research cannot be overstated. In the most recent episode of the Scope of Things podcast, host Deborah Borfitz speaks with Bethany Kwan, University of Colorado Anschutz Medical Campus, and Heather Smyth, Colorado School of Public Health. Together they explore the fundamental distinctions between traditional clinical trials and pragmatic research approaches, uncovering why this methodology is experiencing such significant growth in modern healthcare research.

Jul 7, 2025, 08:28 by

Jul 7, 2025, 08:28 by

CD Bioparticles announces its custom synthesis services of Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles (MNPs).

Jul 7, 2025, 08:28 by

Creative Diagnostics launches Microbial Genome Editing services to support bioresearch.

Jul 3, 2025, 08:20 by

The deal pairs San Juan, Puerto Rico site’s deep community ties, top-tier enrollment, and 90% retention with Headlands’ network-wide infrastructure and resources to accelerate clinical research

Jul 3, 2025, 08:20 by

PHARMASEAL, provider of the Engility® Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF), has announced a Technology Integration Partnership with Viedoc, a global leader in Electronic Data Capture (EDC) and eClinical technologies. This collaboration integrates PHARMASEAL’s advanced CTMS platform with Viedoc’s cutting-edge EDC capabilities, including its flagship product Viedoc Clinic, to deliver a more integrated solution for life science companies managing clinical trials worldwide.